The Checklist of Obtainable Names in Zoology (LAN) is a listing of names with particular scope in time and content material, offered and permitted in components, and constituted as a cumulative index of names obtainable to be used in zoological nomenclature. It was outlined in Article 79 within the fourth version of the Worldwide Code of Zoological Nomenclature. The LAN is prone to achieve significance with the event of the net Official Registry for Zoological Nomenclature (ZooBank) as it’s doubtlessly a supply of many nomenclaturally licensed names. Article 79 describes the deliberative course of for including giant numbers of names to the LAN concurrently, detailing steps and chronology for submission of a candidate Half to the LAN and consideration of a candidate Half by the general public and Fee, however it’s largely mute in regards to the contents of a candidate Half.
It does clarify {that a} title inside the scope of a Half however not on the LAN has no nomenclatural standing, even when it had beforehand been thought-about obtainable, thereby stopping long-forgotten names from displacing accepted ones and the buildup of nomina dubia. Thus, for taxa on the LAN, nomenclatural archaeology – the resurrecting of outdated unused names to switch by precedence names in present utilization – is not going to be worthwhile.
Past that, it has been unclear if Article 79 is meant to doc each obtainable title identified inside the scope of the Half, or if its intention is to pare the stock of obtainable names inside the scope of the Half. Consideration by the Fee and two committees to take care of the LAN have outlined steps to implement Article 79 with the latter intent. Procedures for consideration of a candidate Half are outlined in a guide, printed as an appendix on this quantity.
From experimental zoology to massive information: Remark and integration within the examine of animal improvement.
The founding of the Journal of Experimental Zoology in 1904 was impressed by a widespread flip towards experimental biology within the 19th century. The founding editors sought to advertise experimental, laboratory-based approaches, significantly in developmental biology. This agenda raised key sensible and epistemological questions on how and the place to check improvement: Does the setting matter? How do we all know {that a} cell or embryo remoted to facilitate remark reveals regular developmental processes? How can we combine descriptive and experimental information? R.G. Harrison, the journal’s first editor, grappled with these questions in justifying his use of cell tradition to check neural patterning.
Others confronted them in several contexts: for instance, F.B. Sumner insisted on the primacy of fieldwork in his research on adaptation, but in addition carried out breeding experiments utilizing wild-collected animals. The work of Harrison, Sumner, and different early contributors exemplified each the ability of latest methods, and the meticulous rationalization of apply and epistemology that was marshaled to advertise experimental approaches. A century later, experimentation is extensively considered as the usual option to examine improvement; but on the similar time, cutting-edge “massive information” initiatives are primarily descriptive, nearer to pure historical past than to the approaches championed by Harrison et al. Thus, the unique questions on how and the place we will greatest find out about improvement are nonetheless with us. Inspecting their historical past can inform present efforts to include information from experiment and outline, lab and discipline, and a broad vary of organisms and disciplines, into an built-in understanding of animal improvement.
Controlling and culturing variety: experimental zoology earlier than World Conflict II and Vienna’s Biologische Versuchsanstalt.
Based in Vienna in 1903, the Institute for Experimental Biology pioneered the applying of experimental strategies to residing organisms maintained for sustained intervals in captivity. Its Director, the zoologist Hans Przibram, oversaw till 1938, the try to combine ontogeny with research of inheritance utilizing exact and managed measurements of the influence of environmental influences on the emergence of type and performance. Within the early years, these efforts paralleled and even fostered the emergence of experimental biology in America.
However destiny intervened. Although the Institute served a global group, most of its resident scientists and employees have been of Jewish ancestry. Effectively earlier than the Nazis entered Austria in 1938, these women and men have been being fired and pushed out; some, together with Przibram, have been ultimately killed. We describe the unprecedented services constructed and the subjects addressed by the a number of departments that made up this Institute, stressing these most related to the institution and success of the Journal of Experimental Zoology, which was based only a 12 months later. The Institute’s diaspora left an vital legacy in North America, maybe greatest embodied by the profession of the developmental neuroscientist Paul Weiss.
[Zoological diagnostics of soils: imperatives, purposes, and place within soil zoology and pedology].
Zoological diagnostics of soils was conceived by M.S. Ghilarov as part of soil zoology and meant to be carefully associated to pedology. He thought-about zoo-agents as an ecological issue, one amongst many others, of soil formation. Up to date soil diagnostics pursues principally utilitarian targets and relies on conservative properties of the steady a part of soil substrate. Nonetheless, it’s admitted that these properties are generated by particular mixtures of organic, chemical, and bodily phenomena which can be referred to as “elementary soil processes” (ESP) and happen nowhere however in soils.
Sure ESPs are related to distinctive mixtures of biota, together with invertebrates. Pedobionts act as producers of detritus and contribute to humus formation, which is important for any ESP beginning, thus being its lively celebration. That’s the reason animals, being essentially the most advanced and lively a part of the ESP system, could also be handled not solely as its indicators but in addition as its navigators. Monitoring and learning of ESPs in soil is sophisticated due to inevitable disturbance of soil profile pure composition.
Rapamycin |
20-abx185560 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Rapamycin |
E1B1842 |
EnoGene |
1mg |
EUR 60 |
Rapamycin |
G613 |
ABM |
100 mg |
EUR 800 |
Rapamycin |
R001-10MG |
TOKU-E |
10 mg |
EUR 149.37 |
|
Description: C51H79NO13 |
Rapamycin |
R001-25MG |
TOKU-E |
25 mg |
EUR 187.13 |
|
Description: C51H79NO13 |
Rapamycin |
SIH-212-25MG |
Stressmarq |
25 mg |
EUR 345 |
Description: mTOR inhibitor |
Rapamycin |
SIH-212-5MG |
Stressmarq |
5 mg |
EUR 138 |
Description: mTOR inhibitor |
Rapamycin |
abx076788-100l |
Abbexa |
100 µl |
EUR 118.75 |
Rapamycin |
abx076788-1ml |
Abbexa |
1 ml |
Ask for price |
Rapamycin |
abx076788-200l |
Abbexa |
200 µl |
EUR 300 |
Rapamycin |
MBS407517-5x100mg |
MyBiosource |
5x100mg |
EUR 730 |
Rapamycin |
MBS3604884-5x200mg |
MyBiosource |
5x200mg |
EUR 760 |
Rapamycin |
MBS515013-5x100mg |
MyBiosource |
5x100mg |
EUR 2740 |
Rapamycin, 100mg |
R5312 |
ACTGene |
100mg |
EUR 607.18 |
|
Rapamycin, 100mg |
R5312-100mg |
ACTGene |
each |
EUR 902.4 |
Rapamycin, >99% |
BC082-050 |
GenDepot |
50mg |
EUR 262.8 |
Rapamycin, >99% |
BC082-100 |
GenDepot |
100mg |
EUR 313.2 |
Rapamycin, >99% |
BC082-250 |
GenDepot |
250mg |
EUR 424.8 |
Rapamycin, >99% |
BC082-500 |
GenDepot |
500mg |
EUR 651.6 |
Rapamycin (GMP) |
HY-10219G |
MedChemExpress |
Get quote |
Ask for price |
Description: Rapamycin (Sirolimus) (GMP) is Rapamycin (HY-10219) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Rapamycin is a potent and specific mTOR inhibitor[1][2][3]. |
Rapamycin-13C,d3 |
HY-10219S1 |
MedChemExpress |
Get quote |
Ask for price |
Description: Rapamycin-13C,d3 (Sirolimus-13C,d3; AY-22989-13C,d3) is the 13C and deuterium labeled Rapamycin (HY-10219)[1]. Rapamycin (Sirolimus; AY 22989) is a potent and specific mTOR inhibitor with an IC50 of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1[2]. Rapamycin is an autophagy activator, an immunosuppressant[3]. |
Rapamycin, 10mg |
R5312-10mg |
ACTGene |
each |
EUR 244.8 |
Seco Rapamycin |
MBS5799522-5x5mg |
MyBiosource |
5x5(mg |
EUR 3970 |
Rapamycin-d3 |
HY-10219S |
MedChemExpress |
1 mg |
EUR 119.05 |
Description: Rapamycin-d3 is the deuterium labeled Rapamycin. Rapamycin is a potent and specific mTOR inhibitor with an IC50of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1[1]. Rapamycin is an autophagy activator, an immunosuppressant[2]. |
Rapamycin (Sirolimus) |
E1KS1039 |
EnoGene |
50mg |
EUR 120 |
Rapamycin (Sirolimus) |
A8167-100 |
ApexBio |
100 mg |
EUR 154 |
|
Description: Original antifungal antibiotic |
Rapamycin (Sirolimus) |
A8167-25 |
ApexBio |
25 mg |
EUR 74 |
|
Description: Original antifungal antibiotic |
Rapamycin (Sirolimus) |
A8167-5 |
ApexBio |
5 mg |
EUR 33 |
|
Description: Original antifungal antibiotic |
Rapamycin (Sirolimus) |
A8167-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 48 |
|
Description: Original antifungal antibiotic |
Rapamycin (Sirolimus) |
A8167-S |
ApexBio |
Evaluation Sample |
EUR 22 |
|
Description: Original antifungal antibiotic |
Rapamycin (Sirolimus) |
MBS8506576-50mg |
MyBiosource |
50mg |
EUR 210 |
Rapamycin (Sirolimus) |
MBS8506576-5x50mg |
MyBiosource |
5x50mg |
EUR 800 |
Rapamycin (Sirolimus) |
MBS386035-100mg |
MyBiosource |
100mg |
EUR 160 |
Rapamycin (Sirolimus) |
MBS386035-1mLinDMSO |
MyBiosource |
1mL(inDMSO) |
EUR 140 |
Rapamycin (Sirolimus) |
MBS386035-50mg |
MyBiosource |
50mg |
EUR 145 |
Rapamycin (Sirolimus) |
MBS386035-5mg |
MyBiosource |
5mg |
EUR 130 |
Rapamycin (Sirolimus) |
MBS386035-5x100mg |
MyBiosource |
5x100mg |
EUR 715 |
Rapamycin (Sirolimus) |
MBS575148-100mg |
MyBiosource |
100mg |
EUR 155 |
Rapamycin (Sirolimus) |
MBS575148-200mg |
MyBiosource |
200mg |
EUR 185 |
Rapamycin (Sirolimus) |
MBS575148-25mg |
MyBiosource |
25mg |
EUR 135 |
Rapamycin (Sirolimus) |
MBS575148-500mg |
MyBiosource |
500mg |
EUR 260 |
Rapamycin (Sirolimus) |
MBS575148-50mg |
MyBiosource |
50mg |
EUR 145 |
EZSolution? Rapamycin |
1746-5 |
Biovision |
each |
EUR 326.4 |
Rapamycin analog-2 |
HY-153511 |
MedChemExpress |
Get quote |
Ask for price |
Description: Rapamycin analog-2 (compound A) is a Rapamycin analog[1]. |
TOR | Target of rapamycin |
AS12-2608 |
Agrisera AB |
50 µg |
EUR 302 |
7-O-Demethyl rapamycin |
T25882-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: 7-O-Demethyl rapamycin |
7-O-Demethyl rapamycin |
T25882-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: 7-O-Demethyl rapamycin |
7-O-Demethyl rapamycin |
T25882-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: 7-O-Demethyl rapamycin |
7-O-Demethyl rapamycin |
T25882-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: 7-O-Demethyl rapamycin |
7-O-Demethyl rapamycin |
T25882-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: 7-O-Demethyl rapamycin |
Seco Rapamycin sodium salt |
T19558-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Seco Rapamycin sodium salt |
Seco Rapamycin sodium salt |
T19558-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Seco Rapamycin sodium salt |
Seco Rapamycin sodium salt |
T19558-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Seco Rapamycin sodium salt |
Seco Rapamycin sodium salt |
T19558-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Seco Rapamycin sodium salt |
Seco Rapamycin sodium salt |
T19558-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Seco Rapamycin sodium salt |
7-O-Demethyl Rapamycin |
MBS6080732-25mg |
MyBiosource |
2.5(mg |
EUR 665 |
7-O-Demethyl Rapamycin |
MBS6080732-5x25mg |
MyBiosource |
5x2.5mg |
EUR 2845 |
7-O-Demethyl rapamycin |
MBS5775613-10mg |
MyBiosource |
10mg |
EUR 2020 |
7-O-Demethyl rapamycin |
MBS5775613-25mg |
MyBiosource |
25mg |
EUR 1995 |
7-O-Demethyl rapamycin |
MBS5775613-5mg |
MyBiosource |
5(mg |
EUR 1235 |
Seco Rapamycin sodium salt |
MBS3602049-10mg |
MyBiosource |
10mg |
EUR 655 |
Seco Rapamycin sodium salt |
MBS3602049-25mg |
MyBiosource |
25mg |
EUR 1075 |
Seco Rapamycin sodium salt |
MBS3602049-50mg |
MyBiosource |
50mg |
EUR 1630 |
Seco Rapamycin sodium salt |
MBS3602049-5mg |
MyBiosource |
5mg |
EUR 465 |
Seco Rapamycin sodium salt |
MBS3602049-5x50mg |
MyBiosource |
5x50mg |
EUR 7015 |
Seco Rapamycin sodium salt |
MBS5756112-25mg |
MyBiosource |
25mg |
EUR 1405 |
Seco Rapamycin sodium salt |
MBS5756112-50mg |
MyBiosource |
50mg |
EUR 2410 |
Seco Rapamycin sodium salt |
MBS5756112-5x50mg |
MyBiosource |
5x50mg |
EUR 10695 |
Seco Rapamycin ethyl ester |
HY-133770 |
MedChemExpress |
10 mg |
EUR 2380.99 |
Description: Seco Rapamycin ethyl ester is an open-ring metabolite of Rapamycin derivative. Seco-rapamycin is reported not to affect the mTOR function[1]. |
7-O-Demethyl rapamycin |
HY-123691 |
MedChemExpress |
Get quote |
Ask for price |
Description: 7-O-Demethyl rapamycin, a derivative of Rapamycin (HY-10219), has antifungal activity and immunosuppressant properties. 7-O-Demethyl rapamycin has useful tumor cell growth-inhibiting activity[1]. |
42-(2-Tetrazolyl)rapamycin |
T10158-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: 42-(2-Tetrazolyl)rapamycin |
42-(2-Tetrazolyl)rapamycin |
T10158-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: 42-(2-Tetrazolyl)rapamycin |
42-(2-Tetrazolyl)rapamycin |
T10158-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: 42-(2-Tetrazolyl)rapamycin |
42-(2-Tetrazolyl)rapamycin |
T10158-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: 42-(2-Tetrazolyl)rapamycin |
42-(2-Tetrazolyl)rapamycin |
T10158-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: 42-(2-Tetrazolyl)rapamycin |
42-(2-Tetrazolyl)rapamycin |
MBS3845824-100mg |
MyBiosource |
100mg |
EUR 3100 |
42-(2-Tetrazolyl)rapamycin |
MBS3845824-10mg |
MyBiosource |
10mg |
EUR 575 |
42-(2-Tetrazolyl)rapamycin |
MBS3845824-50mg |
MyBiosource |
50mg |
EUR 1585 |
42-(2-Tetrazolyl)rapamycin |
MBS3845824-5mg |
MyBiosource |
5mg |
EUR 355 |
42-(2-Tetrazolyl)rapamycin |
MBS3845824-5x100mg |
MyBiosource |
5x100mg |
EUR 13945 |
42-(2-Tetrazolyl)rapamycin |
MBS5752629-50mg |
MyBiosource |
50mg |
EUR 1325 |
42-(2-Tetrazolyl)rapamycin |
MBS5752629-5x50mg |
MyBiosource |
5x50mg |
EUR 5800 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6507975-01mg |
MyBiosource |
0.1mg |
EUR 730 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6507975-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3140 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6241926-01mL |
MyBiosource |
0.1(mL |
EUR 1020 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6241926-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4440 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6244057-01mL |
MyBiosource |
0.1(mL |
EUR 1020 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6244057-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4440 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6244590-01mL |
MyBiosource |
0.1(mL |
EUR 1020 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6244590-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4440 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6245123-01mL |
MyBiosource |
0.1(mL |
EUR 1020 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6245123-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4440 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6245656-01mL |
MyBiosource |
0.1(mL |
EUR 1020 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6245656-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4440 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6247255-01mL |
MyBiosource |
0.1(mL |
EUR 1020 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6247255-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4440 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6246189-01mL |
MyBiosource |
0.1(mL |
EUR 1020 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6246189-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4440 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6246722-01mL |
MyBiosource |
0.1(mL |
EUR 1020 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6246722-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4440 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6243524-01mL |
MyBiosource |
0.1(mL |
EUR 1020 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6243524-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4440 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6242459-01mL |
MyBiosource |
0.1(mL |
EUR 1020 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6242459-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4440 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6242991-01mL |
MyBiosource |
0.1(mL |
EUR 1020 |
mTOR (Mammalian target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), FK506-binding Protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, Rapamycin Ta |
MBS6242991-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4440 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6141966-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6141966-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6136663-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6136663-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6131360-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6131360-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6200898-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6200898-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6211573-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6211573-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6147269-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6147269-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6157875-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6157875-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6190223-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6190223-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6152572-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6152572-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6222248-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6222248-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6232923-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
FRAP1 (Serine/Threonine-protein Kinase mTOR, Mechanistic Target Of Rapamycin, FK506-binding Protein 12-rapamycin Complex-associated Protein 1, FKBP12-rapamycin Complex-associated Protein, Rapamycin Target Protein 1, RAPT1, Mammalian Target Of Rapamycin, m |
MBS6232923-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
Rapamycin (FRAP, mTOR Inhibitor, Sirolimus) |
MBS655453-10mg |
MyBiosource |
10mg |
EUR 260 |
Rapamycin (FRAP, mTOR Inhibitor, Sirolimus) |
MBS655453-250mg |
MyBiosource |
250mg |
EUR 1005 |
Rapamycin (FRAP, mTOR Inhibitor, Sirolimus) |
MBS655453-500mg |
MyBiosource |
500mg |
EUR 1495 |
Rapamycin (FRAP, mTOR Inhibitor, Sirolimus) |
MBS655453-50mg |
MyBiosource |
50mg |
EUR 610 |
Zoo-agents, on the similar time, could be registered with out habitats altering. Bearing in mind ecological efficiency of soil invertebrates that take part in an ESP, spectra of their eco-groups, life types, and outcomes of their exercise, it’s attainable to diagnose a soil state at completely different levels of sure ESPs improvement, with their completely different mixtures, and in several areas or components of pure environmental gradients.